Wird geladen...
Optimization of RGD-modified Nano-liposomes Encapsulating Eptifibatide
BACKGROUND: Eptifibatide (Integrilin) is an intravenous (IV) peptide drug that selectively inhibits ligand binding to the platelet GP IIb/IIIa receptor. It is an efficient peptide drug, however has a short half-life. Therefore, antithrombotic agents like eptifibatide are required to become improved...
Gespeichert in:
| Veröffentlicht in: | Iran J Biotechnol |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
National Institute of Genetic Engineering and Biotechnology
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5435030/ https://ncbi.nlm.nih.gov/pubmed/28959324 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15171/ijb.1399 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|